Clear ×
Mineralys Therapeutics, Inc. MLYS

Showing 10-K, 10-Q & 8-K from the last 6 months. Need full history or all form types?

Oct 19, 2026 8-K 2 signals fired
Other
Rsu Psu Vesting Schedule Disclosed Classified Board Director Election
Aug 11, 2026 10-Q 61 signals fired · top 15
Other
Change Of Control Definition New York Jurisdiction Clause Net Loss Reported Cash Flow Statement Investing Activities Restrictive Debt Covenants Disclosure Amendment Modification Waiver Clause Financing Activities Cash Flow Disclosure Arbitrator Selection Procedure Fcpa Compliance Representation Liquidity Position Snapshot Disclosed Sanctions Compliance Representation Incorporation Or Reincorporation Disclosure Capital Raising Uncertainty Disclosed Libor Based Term Loan Pricing Shares Outstanding Disclosure
Aug 11, 2026 8-K 15 signals fired
Other
Net Loss Reported Liquidity Position Snapshot Disclosed Priority Review Or Pdufa Disclosed Amendment Modification Waiver Clause New York Jurisdiction Clause Earnings Call Replay Details Kol Endorsement Enrollment Ahead Of Schedule Personnel Cost Decrease Disclosure Interim Data Positive Equity Plan Board Approval Conditional On Shareholder Vote
Core
Near Term Regulatory Decision Indication Expansion Lead Asset Progress Clinical Trial Result
Jun 3, 2026 8-K 22 signals fired · top 15
Other
New York Jurisdiction Clause Fcpa Compliance Representation Ipo Net Proceeds Disclosure Sanctions Compliance Representation Corporate Organization And Standing Representation Use Of Proceeds Disclosure Director Officer Indemnification Provision Form S3 Shelf Registration Disclosure Legal Opinion Methodology Disclosure No Regulatory Approval Required Closing Condition Opinions And Certificates Registration Rights Piggyback Provision Corporate Authority Representation Conflicted Defense Counsel Provision Prospectus Supplement Disclosure
Jun 3, 2026 8-K 4 signals fired
Other
Restrictive Debt Covenants Disclosure Libor Based Term Loan Pricing Event Of Default Defined Term Loan B Holding Disclosure
May 22, 2026 8-K 2 signals fired
Other
Auditor Appointment Ratification Classified Board Director Election
May 6, 2026 8-K 13 signals fired
Other
Net Loss Reported Liquidity Position Snapshot Disclosed Priority Review Or Pdufa Disclosed Personnel Cost Decrease Disclosure Kol Endorsement Earnings Call Replay Details Interim Data Positive Enrollment Ahead Of Schedule Burn Rate Controlled
Core
Lead Asset Progress Clinical Trial Result Indication Expansion Near Term Regulatory Decision